KAREN J WILSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KAREN J WILSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KAREN J WILSON. KAREN J WILSON is Director in Vaxart, Inc. ($VXRT) and Vice President, CFO in Monogram Biosciences, Inc. ($VLGC) and SVP, Finance & PAO in Jazz Pharmaceuticals plc ($JAZZ) and Director in Angion Biomedica Corp. ($ANG).
Latest Insider Trading Transactions of KAREN J WILSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANG, JAZZ, VLGC, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | ANG | Angion Biomedica C ... | WILSON KAREN J | Director | Option Exercise | A | 15.01 | 15,000 | 225,150 | 15,000 | |
| Feb 11 2021 | ANG | Angion Biomedica C ... | WILSON KAREN J | Director | Buy | C | 11.57 | 18,718 | 216,567 | 18,718 | 0 to 18.7 K |
| Aug 27 2020 | VXRT | Vaxart, Inc. | WILSON KAREN J | Director | Option Exercise | A | 6.95 | 65,700 | 456,615 | 65,700 | |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 135.82 | 302 | 41,018 | 18,385 | 18.7 K to 18.4 K (-1.62 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 135.82 | 276 | 37,486 | 18,687 | 19 K to 18.7 K (-1.46 %) |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.03 | 8,174 | 1,144,605 | 8,174 | |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.03 | 576 | 80,657 | 576 | |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,500 | 0 | 18,963 | 15.5 K to 19 K (+22.63 %) |
| Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 127.76 | 230 | 29,385 | 15,463 | 15.7 K to 15.5 K (-1.47 %) |
| Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 126.25 | 310 | 39,138 | 15,693 | 16 K to 15.7 K (-1.94 %) |
| May 15 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 165.01 | 54 | 8,910 | 15,757 | 15.8 K to 15.8 K (-0.34 %) |
| May 15 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 165.00 | 3,706 | 611,490 | 15,811 | 19.5 K to 15.8 K (-18.99 %) |
| Apr 12 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 155.00 | 3,899 | 604,345 | 19,517 | 23.4 K to 19.5 K (-16.65 %) |
| Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 143.39 | 302 | 43,304 | 23,416 | 23.7 K to 23.4 K (-1.27 %) |
| Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.67 | 7,319 | 1,029,564 | 7,319 | |
| Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.67 | 681 | 95,796 | 681 | |
| Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,200 | 0 | 23,718 | 20.5 K to 23.7 K (+15.60 %) |
| Feb 28 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 143.80 | 324 | 46,591 | 20,518 | 20.8 K to 20.5 K (-1.55 %) |
| Feb 28 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 147.44 | 537 | 79,175 | 20,842 | 21.4 K to 20.8 K (-2.51 %) |
| Apr 27 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 160.00 | 1,275 | 204,000 | 21,133 | 22.4 K to 21.1 K (-5.69 %) |
| Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 4,750 | 280,868 | 0 | |
| Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 6,708 | 314,136 | 0 | |
| Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 152.24 | 6,708 | 1,021,226 | 22,408 | 29.1 K to 22.4 K (-23.04 %) |
| Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 6,708 | 314,136 | 29,116 | 22.4 K to 29.1 K (+29.94 %) |
| Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 152.24 | 4,750 | 723,140 | 22,408 | 27.2 K to 22.4 K (-17.49 %) |
| Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 4,750 | 280,868 | 27,158 | 22.4 K to 27.2 K (+21.20 %) |
| Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 750 | 44,348 | 0 | |
| Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 2,896 | 135,620 | 0 | |
| Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 750 | 44,348 | 22,408 | 21.7 K to 22.4 K (+3.46 %) |
| Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 2,896 | 135,620 | 21,658 | 18.8 K to 21.7 K (+15.44 %) |
| Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 132.81 | 563 | 74,772 | 18,762 | 19.3 K to 18.8 K (-2.91 %) |
| Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 136.18 | 7,781 | 1,059,617 | 7,781 | |
| Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 136.18 | 969 | 131,958 | 969 | |
| Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,500 | 0 | 19,325 | 15.8 K to 19.3 K (+22.12 %) |
| Mar 01 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 136.97 | 935 | 128,067 | 15,825 | 16.8 K to 15.8 K (-5.58 %) |
| Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 150.01 | 1,467 | 220,065 | 16,710 | 18.2 K to 16.7 K (-8.07 %) |
| Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 150.01 | 1,467 | 220,065 | 16,710 | 18.2 K to 16.7 K (-8.07 %) |
| Apr 27 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 160.00 | 604 | 96,640 | 18,059 | 18.7 K to 18.1 K (-3.24 %) |
| Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 127.84 | 563 | 71,974 | 25,831 | 26.4 K to 25.8 K (-2.13 %) |
| Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 121.58 | 348 | 42,310 | 26,394 | 26.7 K to 26.4 K (-1.30 %) |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 123.36 | 7,511 | 926,557 | 7,511 | |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 123.36 | 739 | 91,163 | 739 | |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 125.00 | 285 | 35,625 | 26,742 | 27 K to 26.7 K (-1.05 %) |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,300 | 0 | 27,027 | 23.7 K to 27 K (+13.91 %) |
| Apr 15 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 150.00 | 5,007 | 751,050 | 18,663 | 23.7 K to 18.7 K (-21.15 %) |
| Apr 08 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 140.90 | 2,161 | 304,485 | 23,670 | 25.8 K to 23.7 K (-8.37 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 181.48 | 1,956 | 354,975 | 23,686 | 25.6 K to 23.7 K (-7.63 %) |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 1,500 | 88,695 | 4,750 | |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 3,994 | 187,039 | 6,708 | |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 180.00 | 257 | 46,260 | 25,642 | 25.9 K to 25.6 K (-0.99 %) |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 179.50 | 3,994 | 716,923 | 25,899 | 29.9 K to 25.9 K (-13.36 %) |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 3,994 | 187,039 | 29,893 | 25.9 K to 29.9 K (+15.42 %) |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 179.75 | 1,500 | 269,625 | 25,899 | 27.4 K to 25.9 K (-5.47 %) |
| Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 1,500 | 88,695 | 27,399 | 25.9 K to 27.4 K (+5.79 %) |
| Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 174.76 | 563 | 98,390 | 25,642 | 26.2 K to 25.6 K (-2.15 %) |
| Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 152 | 7,118 | 2,896 | |
| Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 27.46 | 5,007 | 137,492 | 0 | |
| Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 27.46 | 5,007 | 137,492 | 26,205 | 21.2 K to 26.2 K (+23.62 %) |
| Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 152 | 7,118 | 21,198 | 21 K to 21.2 K (+0.72 %) |
| Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 176.27 | 2,598 | 457,949 | 21,046 | 23.6 K to 21 K (-10.99 %) |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 175.19 | 6,435 | 1,127,348 | 6,435 | |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 175.19 | 565 | 98,982 | 565 | |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 170.09 | 373 | 63,444 | 23,644 | 24 K to 23.6 K (-1.55 %) |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 2,685 | 0 | 24,017 | 21.3 K to 24 K (+12.59 %) |
| Mar 25 2004 | VLGC | Monogram Bioscienc ... | WILSON KAREN J | Vice President, CFO | Option Exercise | A | 1.51 | 50,000 | 75,500 | 50,000 | |
| Mar 25 2004 | VLGC | Monogram Bioscienc ... | WILSON KAREN J | Vice President, CFO | Option Exercise | A | 1.51 | 50,000 | 75,500 | 50,000 | |
| Mar 19 2004 | VLGC | Monogram Bioscienc ... | WILSON KAREN J | Vice President, CFO | Option Exercise | A | 3.00 | 75,000 | 225,000 | 75,000 |
Page: 1